DNA Repair-Deficiency Disorders - 15 Studies Found

Not yet recruiting : Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors
: Cancers With DNA Repair-Deficiency
: 2017-03-31
:
  • Drug: Olaparib Olaparib 150 mg
Recruiting : Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
:
  • Hormone-Resistant Prostate Cancer
  • Metastatic Prostate Carcinoma
  • Drug: Carboplatin Chemotherapy
Completed : Neonatal Screening of Severe Combined Immunodeficiencies
:
  • Severe Combined Immunodeficiency
  • Neonatal Screening

: 2015-10-27
Active, not recruiting : Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
:
  • Immune System Disorder
  • Severe Combined Immunodeficiency

: 2001-01-06
:
  • Drug: cyclosporine Given PO or
Not yet recruiting : Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiencies
: Severe Combined Immunodeficiency
: 2016-07-26
: Biological: TBX-1400
Active, not recruiting : Generalized Neonatal Screening of Severe Combined Immunodeficiencies
: Severe Combined Immunodeficiency, Atypical
: 2014-09-02
: Biological: SCID screening
Active, not recruiting : Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China
: Severe Combined Immunodeficiency
: 2014-09-01
: Genetic: gene sequencing Amplify and identify exons from gene IL-2RG by PCR and agarose gel electrophore
Withdrawn : Sirolimus Prophylaxis for aGVHD in TME SCID
:
  • Severe Combined Immunodeficiency
  • Transplacental Maternal Engraftment
  • Biological: unrelated BM with T cell depletion

Terminated : Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim
: Severe Combined Immunodeficiency
: 2010-08-09
:
  • Drug: Transplant Conditioning with Mobilization Only

Next >>>